Your browser doesn't support javascript.
COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth.
Renner, Andreas; Marth, Katharina; Patocka, Karin; Idzko, Marco; Pohl, Wolfgang.
  • Renner A; Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Vienna, Austria.
  • Marth K; Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Vienna, Austria.
  • Patocka K; Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Vienna, Austria.
  • Idzko M; Dept of Pulmonology, Medical University of Vienna, Vienna, Austria.
  • Pohl W; Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Vienna, Austria.
ERJ Open Res ; 6(4)2020 Oct.
Article in English | MEDLINE | ID: covidwho-951520
ABSTRACT
Experience with very mild #COVID19 disease courses in two severe eosinophilic asthmatics with complete eosinophil depletion due to benralizumab treatment counters the recent theories that eosinophilia is protective in COVID-19 infections https//bit.ly/3cnEFvg.

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2020 Document Type: Article Affiliation country: 23120541.00457-2020

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2020 Document Type: Article Affiliation country: 23120541.00457-2020